Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study (Q34913612)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study |
scientific article |
Statements
1 reference
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study (English)
1 reference
David M Brown
1 reference
Mark Michels
1 reference
Peter K Kaiser
1 reference
Jeffrey S Heier
1 reference
Judy P Sy
1 reference
Tsontcho Ianchulev
1 reference
ANCHOR Study Group
1 reference
1 January 2009
1 reference
1 reference
Identifiers
1 reference